Search research articles
Contact Us
Filters
Showing results (11-20 of 112) with videos related to
Page
of 12
Sort By:
International Journal of Cancer
|
July 17, 2003
Prognostic value of ERBB family mRNA expression in breast carcinomas
Ivan Bièche, Peter Onody, Sengül Tozlu, et al.
Anticancer Research
|
December 13, 2005
Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma
Céline Bossard, Ivan Bieche, Viviane Le Doussal, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2003
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Elisabeth Longchampt, Thierry Lebret, Vincent Molinie, et al.
Nucleic Acids Research
|
December 7, 2011
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
Sandrine Caputo, Louisa Benboudjema, Olga Sinilnikova, et al.
Oncogene
|
March 16, 2002
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors
Keltouma Driouch, Hans Prydz, Rossana Monese, et al.
Cancer Letters
|
September 18, 2004
Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma
Igor Girault, Catherine Andrieu, Sengül Tozlu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature
Ivan Bièche, Florence Lerebours, Sengül Tozlu, et al.
BMC Cancer
|
July 5, 2015
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
Geraldine Cizeron-Clairac, François Lallemand, Sophie Vacher, et al.
The Journal of Urology
|
February 14, 2006
Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder
Delphine Amsellem-Ouazana, Ivan Bièche, Sengül Tozlu, et al.
Molecular Carcinogenesis
|
May 11, 2013
TPD52 represents a survival factor in ERBB2-amplified breast cancer cells
Nuruliza Roslan, Ivan Bièche, Robert K Bright, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 112) with videos related to
Sort By:
Page
of 12
International Journal of Cancer
|
July 17, 2003
Prognostic value of ERBB family mRNA expression in breast carcinomas
Ivan Bièche, Peter Onody, Sengül Tozlu, et al.
Anticancer Research
|
December 13, 2005
Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma
Céline Bossard, Ivan Bieche, Viviane Le Doussal, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
May 27, 2003
[Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]
Elisabeth Longchampt, Thierry Lebret, Vincent Molinie, et al.
Nucleic Acids Research
|
December 7, 2011
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
Sandrine Caputo, Louisa Benboudjema, Olga Sinilnikova, et al.
Oncogene
|
March 16, 2002
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors
Keltouma Driouch, Hans Prydz, Rossana Monese, et al.
Cancer Letters
|
September 18, 2004
Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma
Igor Girault, Catherine Andrieu, Sengül Tozlu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature
Ivan Bièche, Florence Lerebours, Sengül Tozlu, et al.
BMC Cancer
|
July 5, 2015
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
Geraldine Cizeron-Clairac, François Lallemand, Sophie Vacher, et al.
The Journal of Urology
|
February 14, 2006
Gene expression profiling of ERBB receptors and ligands in human transitional cell carcinoma of the bladder
Delphine Amsellem-Ouazana, Ivan Bièche, Sengül Tozlu, et al.
Molecular Carcinogenesis
|
May 11, 2013
TPD52 represents a survival factor in ERBB2-amplified breast cancer cells
Nuruliza Roslan, Ivan Bièche, Robert K Bright, et al.
Page
of 12